Purchase Order 75D30122P12963
Award Date
11/22/21
Potential Completion Date
11/19/22
Potential Value
$126K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Illumina, Inc. for a maintenance agreement on three Illumina MiSeq sequencing instruments. The contract has a ceiling value of $42,987.00 and a period of performance through September 15, 2024. Illumina is a manufacturer of genomic sequencing and analysis solutions that has supported numerous federal agencies, including the National Institutes of Health (NIH), U.S. Department of...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a 5-year, Firm Fixed Price purchase order valued at $211,080.73 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The award is for maintenance services to support Illumina's sequencing platforms, such as NextSeq, NovaSeq, MiSeq, and iSeq, which are used across federal agencies including the NIH, CDC, USDA, and VA for research and diagnostics...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The contract is for maintenance services on an unspecified range of Illumina's sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models. The contract has a ceiling value of $149,442.60 and an ultimate completion date of September 25, 2017. The contract does not have a set-aside...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
The Centers for Disease Control and Prevention (CDC) awarded a $245,828.32 firm-fixed-price purchase order to Illumina, Inc. for annual maintenance services on Illumina instruments, including the NextSeq1000 and MiSeq, for a 5-year period from September 9, 2024 through September 8, 2029. The services include health checks, preventive maintenance, and repairs as needed. This purchase order was competed with no set-aside designation. Illumina is a manufacturer of sequencing and array-based...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $233,447.32 firm fixed price contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, which has no set-aside designation, is for MISEQ SUPPORT SERVICES with a period of performance ending on March 31, 2028. Illumina, which has a history of providing sequencing systems, reagents, and related services to federal agencies, will...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $54,367.08 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the repair/replacement and advanced support plan for ISEQ equipment, with performance to be completed by August 20, 2028. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq sequencer and MiniSeq system equipment. The total ceiling value of the contract is $144,985.50, with a period of performance ending on May 9, 2016. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and related products to support research and diagnostics at various...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $83,870.68, is for preventative maintenance services on Illumina's MiSeq instruments. The period of performance runs from the award date of July 10, 2018, through June 30, 2023. This award does not utilize a set-aside. Illumina has a history of...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of a MiSeq sequencing system with a one-year maintenance plan. The total potential value of the contract is $111,870.37. Illumina, a manufacturer of genomic sequencing instruments and reagents, has provided similar sequencing systems and related products to various federal agencies in the past, including the National Institutes of Health (NIH), Department of...